These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20397489)

  • 1. Prostate cancer screening: what's a fellow to do?
    Thanel FH; Huntington MK
    S D Med; 2010; Spec No():41-5. PubMed ID: 20397489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
    Kell JS
    Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
    Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
    CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications.
    Gerard MJ; Frank-Stromborg M
    Oncol Nurs Forum; 1998 Oct; 25(9):1561-9. PubMed ID: 9802052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline update: what's the best approach for screening asymptomatic men for prostate cancer?
    Holten KB; Al-Abdulla S
    J Fam Pract; 2009 Dec; 58(12):E2. PubMed ID: 19961813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introducing the 2010 American Cancer Society prostate cancer screening guideline.
    Brawley OW; Gansler T
    CA Cancer J Clin; 2010; 60(2):68-9. PubMed ID: 20200111
    [No Abstract]   [Full Text] [Related]  

  • 7. The Japanese guideline for prostate cancer screening.
    Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
    Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
    Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
    Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for prostate cancer.
    Postma R; Schröder FH
    Eur J Cancer; 2005 Apr; 41(6):825-33. PubMed ID: 15808952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate specific antigen best practice statement: 2009 update.
    Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P
    J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997.
    McDavid K; Melnik TA; Derderian H
    Prev Med; 2000 Sep; 31(3):195-202. PubMed ID: 10964632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer screening. Why the controversy?
    Walther PJ
    Surg Oncol Clin N Am; 1995 Apr; 4(2):315-34. PubMed ID: 7540938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district.
    Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees.
    Bergdahl AG; Aus G; Lilja H; Hugosson J
    Cancer; 2009 Dec; 115(24):5672-9. PubMed ID: 19813273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why the evidence for skin cancer screening is insufficient: lessons from prostate cancer screening.
    Bigby M
    Arch Dermatol; 2010 Mar; 146(3):322-4. PubMed ID: 20231506
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.
    Smith RA; Cokkinides V; Brooks D; Saslow D; Brawley OW
    CA Cancer J Clin; 2010; 60(2):99-119. PubMed ID: 20228384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices.
    Noe M; Schroy P; Demierre MF; Babayan R; Geller AC
    Cancer Causes Control; 2008 Feb; 19(1):1-12. PubMed ID: 17906935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.
    Droz JP; Balducci L; Bolla M; Emberton M; Fitzpatrick JM; Joniau S; Kattan MW; Monfardini S; Moul JW; Naeim A; van Poppel H; Saad F; Sternberg CN
    Crit Rev Oncol Hematol; 2010 Jan; 73(1):68-91. PubMed ID: 19836968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early detection of cancer of the prostate. Pros and cons].
    Hoesl CE; Altwein JE
    MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.